Ipamorelin + Tesamorelin Blend (10mg (5mg + 5mg)) Dosage Protocol
A premium GH secretagogue combination pairing Ipamorelin (selective GHRP) with Tesamorelin (FDA-approved GHRH analog). Tesamorelin provides sustained GHRH stimulation while Ipamorelin amplifies the signal cleanly.
Add 2.0 mL bacteriostatic water → 5 mg/mL total
200-300 mcg Ipamorelin + 1-2mg Tesamorelin daily
At 5 mg/mL: varies by desired ratio
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 2 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Daily | 300 mcg Ipa + 1.5mg Tesa | Once daily |
| Timing | Before bed | On empty stomach |
| Duration | 8-12 weeks | Continuous |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date and concentration, refrigerate immediately
This blend combines the FDA-approved GHRH analog Tesamorelin with the selective GHRP Ipamorelin. Tesamorelin provides sustained GHRH receptor stimulation and has proven efficacy for reducing visceral fat. Ipamorelin amplifies the GH response through ghrelin receptor activation without raising cortisol or prolactin. The combination produces robust, clean GH pulses.
- Tesamorelin is FDA-approved (Egrifta)
- Proven visceral fat reduction
- Clean GH release without side effects
- Supports sleep quality and recovery
- May improve body composition
- Stanley TL, et al. Tesamorelin effects. JAMA. 2014
- Raun K, et al. Ipamorelin selectivity. Eur J Endocrinol. 1998
- Falutz J, et al. Tesamorelin in lipodystrophy. JAIDS. 2010
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 2 weeks
Tesamorelin has shorter reconstituted stability
- •Tesamorelin is FDA-approved for specific indication
- •Ipamorelin is a research compound
- •Shorter reconstituted stability than other blends
- •May cause transient injection site reactions
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.